1. Home
  2. ICCC vs DAVA Comparison

ICCC vs DAVA Comparison

Compare ICCC & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

SELL

Current Price

$10.32

Market Cap

93.1M

Sector

Health Care

ML Signal

SELL

Logo Endava plc (each representing one)

DAVA

Endava plc (each representing one)

HOLD

Current Price

$1.68

Market Cap

108.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICCC
DAVA
Founded
1982
2000
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
93.1M
108.3M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
ICCC
DAVA
Price
$10.32
$1.68
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
★ $3.68
AVG Volume (30 Days)
6.2K
★ 238.3K
Earning Date
11-12-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 53.85
N/A
EPS
★ 0.41
N/A
Revenue
★ $26,493,169.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.70
P/E Ratio
$25.29
★ $20.02
Revenue Growth
★ 51.64
N/A
52 Week Low
$4.52
$1.52
52 Week High
$12.10
$9.47

Technical Indicators

Market Signals
Indicator
ICCC
DAVA
Relative Strength Index (RSI) 52.11 37.20
Support Level $9.45 $1.60
Resistance Level $10.76 $1.98
Average True Range (ATR) 0.22 0.13
MACD -0.02 -0.02
Stochastic Oscillator 48.80 26.21

Price Performance

Historical Comparison
ICCC
DAVA

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

About DAVA Endava plc (each representing one)

Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.

Share on Social Networks: